[9] [10] For patients with established cardiovascular disease, SGLT2 inhibitors are generally prioritised for cardiorenal protection, with GLP-1 receptor agonists with proven cardiovascular benefit considered when SGLT2 inhibitors are unsuitable
The company does not compound, manufacture, or distribute medications directly
Jimnez-RabadnPRamnMGarca-lvarezOMaroto-MoralesA.del OlmoEPrez-GuzmnMDet al
GLP-1 agonists such as Ozempic should generally be avoided in individuals with: A personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN2) A prior history of pancreatitis Progressive diabetic retinopathy, particularly in those with long-standing or poorly controlled diabetes Congestive heart failure, where fluid balance, heart rate, and medication interactions require close monitoring (35) A thorough medical history and medication review are essential before initiating therapy to determine whether GLP-1 agonists are appropriate or contraindicated
Dokmeci D
With just a few precise injections, we can soften forehead lines, frown lines between the brows (the 11s), and crows feet around the eyes